Kidney Health: BIA 28-6156 Study

We are evaluating a new medication for people with varying degrees of kidney impairment. The study focuses on its safety and how the body processes it.

6-12 monthsSafety phase (I)NephrologyNeurology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
CRU Hungary Kft.
Kistarcsa, Hungary
Sponsor: Bial R&D Investments S.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.